Is Carotid Intima-media Thickness Affected by A1C Variability?
This study has been completed.
Sponsor:
Yonsei University
Information provided by:
Yonsei University
ClinicalTrials.gov Identifier:
NCT00842972
First received: February 11, 2009
Last updated: September 14, 2009
Last verified: September 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study was conducted to evaluate the effect of A1C variability on the progression of carotid artery intima-media thickness in type 2 diabetic patients.
| Condition |
|---|
|
Type 2 Diabetes A1C Variability |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
Resource links provided by NLM:
Further study details as provided by Yonsei University:
Eligibility| Ages Eligible for Study: | 34 Years to 79 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Study Population
typeII, Fluroscopy in carotid once a year during 2 years.
Criteria
Inclusion Criteria:
- type II
- fluoroscopy in carotid once a year during 2 years
Exclusion Criteria:
- type 1 diabetes
- history or clinical evidence of coronary artery disease or cerebral or peripheral vascular disease
- the presence of albuminuria (defined as 24 hour urine albumin excretion ≥ 30 mg)
- renal dysfunction (defined as creatinine blood level ≥ 2.0 mg/dL)
- hepatic dysfunction (defined as alanine aminotransferase and/or aspartate aminotransferase blood level ≥ 3 × upper normal limit)
- smoking within the past 3 months prior to commencement of the study
- use of any medication likely to alter IMT such as calcium channel blocker, thiazolidinedione, antiplatelet agent (clopidogrel, cilostazol)
- use of glucocorticoid
- pregnancy
- severe concomitant disease such as cancer
- infection
- Cushing's syndrome
- acromegaly, or any other disorder likely to alter glycemia
- primary hypercholesterolemia
- hypothyroidism or hyperthyroidism
- use of any hormonal drugs
- alcoholism or drug abuse
Contacts and Locations
No Contacts or Locations Provided
More Information
No publications provided
| Responsible Party: | Ahn, Chul Woo, Gangnam Severance Hospital |
| ClinicalTrials.gov Identifier: | NCT00842972 History of Changes |
| Other Study ID Numbers: | 3-2006-0005 |
| Study First Received: | February 11, 2009 |
| Last Updated: | September 14, 2009 |
| Health Authority: | Korea: Food and Drug Administration |
Additional relevant MeSH terms:
|
Diabetes Mellitus, Type 2 Diabetes Mellitus Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |
ClinicalTrials.gov processed this record on May 23, 2013